Covered recipient · General Payments record
FERNANDO ESPARZA-AVILA
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$323.90
- Reported across 22 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $261.39 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABIOMED | $199.02 | 14 |
| Astellas Pharma US Inc | $34.94 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $14.32 | 1 |
| Axsome Therapeutics, Inc. | $13.11 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABIOMED | $5.70 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142303237 | CMS |
| ABIOMED | $7.48 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142303239 | CMS |
| ABIOMED | $8.77 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142303241 | CMS |
| ABIOMED | $6.40 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142303243 | CMS |
| ABIOMED | $24.24 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142303245 | CMS |
| ABIOMED | $15.57 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142303247 | CMS |
| ABIOMED | $11.05 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142303249 | CMS |
| ABIOMED | $17.64 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142303251 | CMS |
| ABIOMED | $23.43 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142303253 | CMS |
| ABIOMED | $23.48 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142303255 | CMS |
| ABIOMED | $7.31 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142303257 | CMS |
| ABIOMED | $6.54 | 11/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142303259 | CMS |
| ABIOMED | $34.89 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142303261 | CMS |
| ABIOMED | $6.52 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142303263 | CMS |
| Astellas Pharma US Inc | $20.97 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139471396 | CMS |
| Astellas Pharma US Inc | $13.97 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139548283 | CMS |
| Axsome Therapeutics, Inc. | $13.11 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148359492 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $14.32 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086366543 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.